
F2G to use $70m financing to advance olorofilm
The financing was co-led by new investors Forbion and Sofinnova Partners. Existing investors, Novo Holdings, Morningside Ventures, Cowen Healthcare...

Sosei announces $1.2bn R&D collaboration with Abbvie
The strategic collaboration leverages Sosei Heptares’ StaR technology and structure-based drug design platform and AbbVie’s extensive...

Unilever launches $120m venture with Genomatica
US biotechnology company Genomatica is a producer of sustainable materials derived from plant- or waste-based feedstocks instead of fossil fuels....

Swedish SOBI awarded rights to market Zynlonta from ADC therapeutics
ADC therapeutics has signed a deal giving Swedish Orphan Biovitrum AB (Sobi) rights to develop and market Zynlonta in hematologic and solid tumor...

Switzerland shows sustained growth of biotech sector
Capital investments in Swiss biotech companies reached the second-best amount ever with CHF3.33bn in the second year of the pandemic, according to...

Roche obtains special authorisation for bispecific antibody
Roches new developed immunotherapy is based on a bispecific antibody, which targets B-lymphocyte antigen CD20 and the CD3-T-cell receptor at the...

Biotalys’ first proteinbased biocontrol shows up in vineyards
Biotalys, the agricultural Technology (AgTech) company in Ghent (Belgium) and listed at EURONEXT (Euronext - BTLS) is devolping protein-based...